Key facts
- Vincent S. LoPriore filed SCHEDULE 13D for Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA).
- Disclosed ownership: 21%.
- Date of event: 21 Apr 2026.
Vincent S. LoPriore - 21 Apr 2026 SCHEDULE 13D Report for Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA)
- Filing Manager
- Vincent S. LoPriore
- Reporting Manager
- Vincent LoPriore
- Symbol
- HEPA
- Shares outstanding
- 29,123,952 shares
- Disclosed Ownership
- 6,250,000 shares
- Ownership
- 21%
- Form type
- SCHEDULE 13D
- Filing time
- 01 May 2026, 17:28:04 UTC
- Date of event
- 21 Apr 2026
- SEC
- View on sec.gov
Key filing fact
Vincent S. LoPriore disclosed 21% ownership in Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA) on 21 Apr 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 01 May 2026, 17:28.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Gravitas Capital LP | 17% | 5,000,000 | 0 | 5,000,000 | /s/ Vincent LoPriore | Vincent LoPriore | 0001840140 |
| Invictus Capital Advisors Pension Plan | 4.3% | 1,250,000 | 1,250,000 | 0 | /s/ Vincent LoPriore | Vincent LoPriore/ Managing Member | |
| Vincent LoPriore | 21% | 6,250,000 | 1,250,000 | 5,000,000 | /s/ Vincent LoPriore | Vincent LoPriore/ Trustee | 0001633927 |
CIK / CUSIP context first